Contact Us

    Your Name (required)

    Your Email (required)

    Your Phone (required)

    Subject

    Interested In... (required)

    Your Message

    ADVANCE – The Official Newsletter of WDSrx (3rd Edition Q2 2017)

    Contact Us

      Your Name (required)

      Your Email (required)

      Your Phone (required)

      Subject

      Interested In... (required)

      Your Message

      Recent Posts

      New Additions and Aspirations at WDSrx: January 2022 News Highlights
      New Additions and Aspirations at WDSrx: January 2022 News Highlights

      February 9, 2022

      Case Study: Custom Labeling Solution Developed For International E-commerce Client
      Case Study: Custom Labeling Solution Developed For International E-commerce Client

      February 2, 2022

      Case Study: Expedited Medical Device Assembly for COVID-19 Self-Test Kits
      Case Study: Expedited Medical Device Assembly for COVID-19 Self-Test Kits

      January 24, 2022

      Case Study: Reducing Wait Times with Expedited Logistics to Cancer Clinics
      Case Study: Reducing Wait Times with Expedited Logistics to Cancer Clinics

      January 13, 2022

      New Year Strategies at WDSrx: December 2021 News Highlights
      New Year Strategies at WDSrx: December 2021 News Highlights

      January 12, 2022

      Search

      Categories

      Print PDF Page

      Are any Controlled Substances (CII) included in your return? If so, please press "Yes" and complete the DEA 222 Request Form. You can also contact Jason Solomon at jsolomon@wdsrx.com or (561) 998-3885 x316.